SanBio CoSNBIF 22 Market Cap is $480.95 Mil as of Jul. 09, 2026. GuruFocus rates SNBIF with a GF Score™ of 22/100. The stock has 1 warning sign investors should review. Among 1,421 Biotechnology companies, SanBio Co ranks better than 69.88% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). SanBio Co's share price for the quarter that ended in Jan. 2026 was $16.45. SanBio Co's Shares Outstanding (EOP) for the quarter that ended in Jan. 2026 was 78.03 Mil. Therefore, SanBio Co's market cap for the quarter that ended in Jan. 2026 was $1,283.64 Mil.
SanBio Co's quarterly market cap
increased
from Jul. 2025 ($1,028.55 Mil) to Oct. 2025 ($1,184.86 Mil) and
increased
from Oct. 2025 ($1,184.86 Mil) to Jan. 2026 ($1,283.64 Mil).
SanBio Co's annual market cap
increased
from Jan. 2024 ($271.72 Mil) to Jan. 2025 ($329.81 Mil) and
increased
from Jan. 2025 ($329.81 Mil) to Jan. 2026 ($1,283.64 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. SanBio Co's Enterprise Value for Today is $379.19 Mil.
SanBio Co (OTCPK:SNBIF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
SanBio Co Market Cap Related Terms
SanBio Co Market Cap Historical Data
* Premium members only.
The historical data trend for SanBio Co's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, SanBio Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SanBio Co Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, SanBio Co's Market Cap distribution charts can be found below:
* The bar in red indicates where SanBio Co's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
SanBio Co's Market Cap for the fiscal year that ended in Jan. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SanBio Co (SNBIF) has a Market Cap of $480.95 Mil as of Jul. 09, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on SanBio Co and its competitors. According to the industry distribution chart, SanBio Co ranks #428 out of 1421 companies in the Biotechnology industry, placing it in the top 30.1%.
Is SanBio Co's Market Cap too high?
SanBio Co's current Market Cap is $480.95 Mil. The Biotechnology industry median Market Cap is 119.86. SanBio Co's value of $480.95 Mil is 301.3% above this industry median. Based on the distribution chart, SanBio Co ranks #428 out of 1421 companies in the Biotechnology industry, which is above the industry midpoint. Overall, SanBio Co has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does SanBio Co's Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, SanBio Co ranks #428 out of 1421 companies for Market Cap. This puts SanBio Co in the upper half of its industry. The industry median Market Cap is 119.86. SanBio Co's value of $480.95 Mil is 301.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 119.86, based on 1,421 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SanBio Co's current Market Cap of $480.95 Mil is 301.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on SanBio Co and its competitors. For the Biotechnology industry, the median Market Cap is 119.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SanBio Co's current Market Cap is $480.95 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SanBio Co stock overvalued right now?
SanBio Co (SNBIF) has a current Market Cap of $480.95 Mil. The current Market Cap is $480.95 Mil and 301.3% above the Biotechnology industry median of 119.86. SanBio Co's overall GF Score™ is 22/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For SanBio Co (SNBIF), the current Market Cap is $480.95 Mil as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
SanBio Co Ltd is engaged in the research and development of regenerative cells drugs. The company has three types of drugs under development, including nerve regeneration cell SB623, used for the treatment of chronic cerebral infarction, traumatic brain injury, age-related macular degeneration, retinitis pigmentosa, Parkinson's disease, spinal cord injury and Alzheimer's disease; enhanced type-mesenchymal stem cells SB618, used to treat peripheral neuropathy, as well as muscle stem cells SB308, used in the treatment of muscular dystrophy.
22GF Score
Get the complete analysis for SNBIF
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SNBIF has been successfully added to your 
